Oncology Institute Inc (TOI) Earning Prediction
Oncology Institute Inc (TOI) is set to release its earnings performance on 03/19 16:05:00 ET in After Hours trading. Consensus forecasts predict a revenue of 141.00M and an earnings per share (EPS) of -0.08 for the . With Intellectia's exclusive AI algorithms, users can predict whether the earnings will beat or miss expectations before the report drops. Leverage this powerful tool to strategize and position your trades ahead of the earnings release!
Earnings Surprise Analysis
TOI Transcript
The earnings call summary and Q&A session indicate positive sentiment: strong revenue growth expectations, improved gross margins, sustainable profitability, and positive free cash flow by Q4 2025. The pharmacy business is expanding, and new contracts are expected to boost growth. Despite some unclear responses, the overall outlook is optimistic, with AI initiatives and strategic expansions. The positive impact of external changes like lower drug costs further supports this view. However, the negative cash flow and reserve adjustments are minor concerns, leading to a positive, but not strong positive, sentiment.
The earnings call highlights strong financial performance with increased pharmacy revenue and improved gross margins. The Q&A section reveals positive insights on drug pricing reforms and growth in patient lives, despite some vague responses from management. Overall, the company's strategic initiatives and financial metrics suggest a positive outlook, likely boosting the stock price by 2% to 8% over the next two weeks.
The earnings call reveals strong financial performance with a 44% increase in gross profit and improved EBITDA, indicating operational efficiency. The company has a robust pipeline, especially in fee-for-service revenue, and is on track for cash flow positivity by Q4 2025. Despite some uncertainties in contract terminations, the overall guidance is optimistic, with significant revenue growth expected. The positive sentiment is further supported by improved margins and cost optimization efforts, suggesting a favorable short-term stock price movement.
The earnings call summary indicates strong financial performance with 21% revenue growth, improved gross profit, and reduced losses. New contracts and cost optimization strategies further strengthen the outlook. Although there are some risks in contractual stability and financial performance, management appears confident in their ability to mitigate these. The Q&A section did not reveal significant negative trends. Overall, the positive financial results and guidance, alongside operational improvements and a commitment to shareholder value, suggest a positive stock price movement in the short term.
TOI Report
Frequently Asked Questions
What is the Oncology Institute Inc {quarter} Earnings Release Date and Time?
Oncology Institute Inc (TOI) is scheduled to release its {quarter} earnings report on Mar 19, 2026, After Hours (approximately 4:00 PM ET). This timing allows investors to react during after-hours trading, with a conference call typically following shortly after.
What Are the Consensus Forecasts for Oncology Institute Inc {quarter} Revenue and EPS?
Analysts' consensus predicts 141.00M in revenue and an EPS of -0.08 for Oncology Institute Inc's {quarter}.
What Does Intellectia's AI Predict for Oncology Institute Inc {quarter} Earnings?
Intellectia's exclusive AI algorithms forecast a {conclusion} for Oncology Institute Inc's {quarter} earnings, with a prediction date of Mar 19, 2026. Oncology Institute Inc {summary}
How Can I Use This Earnings Prediction to Trade TOI Stock?
Leverage Intellectia's AI forecast to position trades ahead of the Mar 19, 2026 release—consider calls for a beat scenario or protective puts for misses. Focus on pre-market volatility, and use the scenario probabilities to build strategies around revenue and guidance updates.
How Accurate Is Intellectia's AI for Earnings Predictions Like Oncology Institute Inc {quarter}?
Intellectia's predictions are backed by rigorous backtesting, showing a high hit rate for Beat and Miss calls compared to traditional analysis. While no forecast is 100% certain, we provide probability-based scenarios (e.g., 50% chance of a *Beat*) and detailed rationales to help you make informed decisions. Combine our insights with your strategy for the best results—it's like having a co-pilot for earnings season! Empowering users to strategize trades before reports drop.
How does AI Earnings Prediction generate its forecasts?
AI Earnings Prediction uses advanced Large Language Models (LLMs) to analyze a wealth of data, including past earnings transcripts, real-time market sentiment, analyst insights, and company news from the last three months. It focuses on key indicators like revenue, EPS, and margins to predict whether a company will *Beat*, *Miss*, or remain Neutral relative to market expectations. Think of it as a super-smart analyst crunching numbers and news 24/7 to give you a trading edge!
When are the predictions available, and how often are they updated?
Predictions are generated two days before a company's earnings release (e.g., 5:00 PM ET on Feb 13 for a Feb 15 report) to capture the latest market and company data. They're updated in real-time if significant news breaks, ensuring you get fresh insights.
Can I use AI Earnings Prediction for all types of stocks?
Currently, AI Earnings Prediction focuses on companies with market caps above $40 billion, covering major players like SPG, AAPL, MSFT, and NVDA for the 2025-2026 earnings seasons. We prioritize high-impact stocks with robust data to ensure reliable forecasts. Stay tuned as we expand coverage to more companies based on user demand!
